title: Two-year outcomes in thoracic transplant recipients after conversion to everolimus with reduced calcineurin inhibitor within a multicenter, open-label, randomized trial.
authors.affiliation: Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. lars.gullestad@medisin.uio.no
authors.forename: Lars
authors.initials: L
authors.lastname: Gullestad
authors.forename: Svend-Aage
authors.initials: SA
authors.lastname: Mortensen
authors.forename: Hans
authors.initials: H
authors.lastname: Eiskjær
authors.forename: Gerdt C
authors.initials: GC
authors.lastname: Riise
authors.forename: Lena
authors.initials: L
authors.lastname: Mared
authors.forename: Oystein
authors.initials: O
authors.lastname: Bjørtuft
authors.forename: Björn
authors.initials: B
authors.lastname: Ekmehag
authors.forename: Kjell
authors.initials: K
authors.lastname: Jansson
authors.forename: Svein
authors.initials: S
authors.lastname: Simonsen
authors.forename: Einar
authors.initials: E
authors.lastname: Gude
authors.forename: Bengt
authors.initials: B
authors.lastname: Rundqvist
authors.forename: Hans E
authors.initials: HE
authors.lastname: Fagertun
authors.forename: Dag
authors.initials: D
authors.lastname: Solbu
authors.forename: Martin
authors.initials: M
authors.lastname: Iversen
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000009:adverse effects / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D000068338:Everolimus; D005919:Glomerular Filtration Rate; D006084:Graft Rejection / Q000453:epidemiology; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology*; D016041:Heart-Lung Transplantation / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D016040:Lung Transplantation / Q000276:immunology / Q000502:physiology*; D020123:Sirolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D048868:Adaptor Proteins, Signal Transducing; C491861:CABIN1 protein, human; D007166:Immunosuppressive Agents; D000068338:Everolimus; D020123:Sirolimus